Board MeetingOutcome of Board Meeting
Kilitch Drugs' board approved Q1 financial results.
Kilitch Drugs (India) LimitedKILITCH · Filed with the exchange
Consolidated Net Sales stood at ₹44.88 Cr, with Profit After Tax at ₹1.97 Cr.
Basic EPS for the quarter was ₹0.83.
No comments yet. Be the first.